Cite
HARVARD Citation
Mahé, E. et al. (2022). Safety of ustekinumab in adolescent patients with moderate‐to‐severe plaque psoriasis: real‐world evidence from an ongoing European study (NCT03218488). Journal of the European Academy of Dermatology and Venereology. pp. e646-e648. [Online].